Dr Reddy's is the first leading pharmaceutical company to obtain approval from the Central Drugs Standard Control Organisation (CDSCO) to introduce Elobixibat in India. Elobixibat works by preventing bile acids from being reabsorbed in the ileum...
The AI-powered smart haemodialysis machine aims to increase access to renal care and reduce costs by up to 75%, bringing the price down to approximately Rs 2 lakh. Nephro Care India Limited (NCIL) is working with the National Institute of...
Lyell Immunopharma, Inc, located in South San Francisco, revealed that it has finalized a deal to purchase ImmPACT Bio USA Inc, a clinical-stage biotech company, as part of its efforts to develop advanced CAR T-cell therapies for cancer...
Dozee, India’s Health AI leader, has unveiled the findings of a landmark study published in the internationally renowned journal Frontiers in Medical Technology. This journal is part of the prestigious Frontiers group. The study was conducted at...
Medtronic plc, a prominent player in healthcare technology worldwide, revealed that the FDA has given the green light for the Affera Mapping and Ablation System with Sphere-9 catheter, a comprehensive HD mapping and PF/RF ablation catheter for...
MHRA is showcasing efforts to train various WHO polio labs worldwide with an advanced molecular direct detection technique that can reduce detection times by 50%, aiding in the global push to eliminate polio and save lives...
Abbott introduced a unique clinical trial aimed at enhancing results in patients with worsening heart failure who may benefit from advanced treatment choices. The TEAM-HF study aims to include a maximum of 850 participants from 75 locations...
Bayer has made an exclusive deal with Dewpoint Therapeutics, Inc. for a heart disease program targeting dilated cardiomyopathy (DCM) patients with specific mutations. This marks the initial opportunity for collaboration between Bayer and Dewpoint...
Matica Biotechnology Inc. (Matica Bio), a company specializing in viral vector development and manufacturing, has revealed the signing of a Letter of Intent (LOI) with KaliVir Immunotherapeutics, a clinical-stage biotechnology company from the U.S...
Merck, a leading pharmaceutical firm, stated that Keytruda (pembrolizumab), their anti-PD-1 therapy, has received approval from the European Commission (EC) for two additional uses in gynaecologic cancers. Keytruda has received initial approval...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")